Evidence map›Paper›PMID 25738463›Full record

ArticleCell metabolism2015

Cutaneous Na+ storage strengthens the antimicrobial barrier function of the skin and boosts macrophage-driven host defense.

Jonathan Jantsch, Valentin Schatz, Diana Friedrich, Agnes Schröder, Christoph Kopp, Isabel Siegert, Andreas Maronna, David Wendelborn, Peter Linz, Katrina J Binger and 18 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell metabolism, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 200 papers.

0numbers the graph read from it
0cells of the map it votes in
200citing papers in PubMed
29.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

200 citing papers in PubMed, 317 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Salt and chronic kidney disease.Nature reviews. Nephrology · 2026
    Review
  6. Estimation of skin sodium content viaMagma (New York, N.Y.) · 2026
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Metal Ion Signaling in Biomedicine.Chemical reviews · 2025
    Review
  19. Review
  20. Review

140 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors at 8 institutions in 2 countries.

Jonathan JantschMicrobiology Institute - Clinical Microbiology, Immunology and Hygiene, Universitätsklinikum Erlangen and Friedrich-Alexander Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany; Institute of Clinical Microbiology and Hygiene, Universitätsklinikum Regensburg and Universität Regensburg, Regensburg, Germany. Electronic address: Jonathan.Jantsch@ukr.de.
Valentin SchatzMicrobiology Institute - Clinical Microbiology, Immunology and Hygiene, Universitätsklinikum Erlangen and Friedrich-Alexander Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany; Institute of Clinical Microbiology and Hygiene, Universitätsklinikum Regensburg and Universität Regensburg, Regensburg, Germany.
Diana FriedrichMicrobiology Institute - Clinical Microbiology, Immunology and Hygiene, Universitätsklinikum Erlangen and Friedrich-Alexander Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany; Interdisciplinary Center for Clinical Research and Department of Nephrology and Hypertension, Universitätsklinikum Erlangen and Friedrich-Alexander Universität (FAU) Erlangen-Nürnberg, Germany.
Agnes SchröderInterdisciplinary Center for Clinical Research and Department of Nephrology and Hypertension, Universitätsklinikum Erlangen and Friedrich-Alexander Universität (FAU) Erlangen-Nürnberg, Germany.
Christoph KoppInterdisciplinary Center for Clinical Research and Department of Nephrology and Hypertension, Universitätsklinikum Erlangen and Friedrich-Alexander Universität (FAU) Erlangen-Nürnberg, Germany.
Isabel SiegertMicrobiology Institute - Clinical Microbiology, Immunology and Hygiene, Universitätsklinikum Erlangen and Friedrich-Alexander Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.
Andreas MaronnaDepartment of Dermatology, Universitätsklinikum Erlangen and Friedrich-Alexander Universität (FAU) Erlangen-Nürnberg, Germany.
David WendelbornMicrobiology Institute - Clinical Microbiology, Immunology and Hygiene, Universitätsklinikum Erlangen and Friedrich-Alexander Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany; Interdisciplinary Center for Clinical Research and Department of Nephrology and Hypertension, Universitätsklinikum Erlangen and Friedrich-Alexander Universität (FAU) Erlangen-Nürnberg, Germany.
Peter LinzInterdisciplinary Center for Clinical Research and Department of Nephrology and Hypertension, Universitätsklinikum Erlangen and Friedrich-Alexander Universität (FAU) Erlangen-Nürnberg, Germany.
Katrina J BingerExperimental and Clinical Research Center (ECRC), an institutional cooperation between the Charité Medical Faculty and the Max-Delbrück Center for Molecular Medicine, Berlin, Germany; Max-Delbrück Center for Molecular Medicine, Berlin Germany.
Matthias GebhardtExperimental and Clinical Research Center (ECRC), an institutional cooperation between the Charité Medical Faculty and the Max-Delbrück Center for Molecular Medicine, Berlin, Germany; Max-Delbrück Center for Molecular Medicine, Berlin Germany.
Matthias HeinigMax-Delbrück Center for Molecular Medicine, Berlin Germany; Department of Computational Biology, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Patrick NeubertInterdisciplinary Center for Clinical Research and Department of Nephrology and Hypertension, Universitätsklinikum Erlangen and Friedrich-Alexander Universität (FAU) Erlangen-Nürnberg, Germany.
Fabian FischerMicrobiology Institute - Clinical Microbiology, Immunology and Hygiene, Universitätsklinikum Erlangen and Friedrich-Alexander Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.
Stefan TeufelDepartment of Internal Medicine 3, Rheumatology and Immunology, Universitätsklinikum Erlangen and Friedrich-Alexander Universität (FAU) Erlangen-Nürnberg, Germany; Institute for Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Jean-Pierre DavidDepartment of Internal Medicine 3, Rheumatology and Immunology, Universitätsklinikum Erlangen and Friedrich-Alexander Universität (FAU) Erlangen-Nürnberg, Germany; Institute for Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Clemens NeufertDepartment of Internal Medicine 1, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg.
Alexander CavallaroDepartment of Radiology, Universitätsklinikum Erlangen and Friedrich-Alexander Universität (FAU) Erlangen-Nürnberg, Germany.
Natalia RakovaExperimental and Clinical Research Center (ECRC), an institutional cooperation between the Charité Medical Faculty and the Max-Delbrück Center for Molecular Medicine, Berlin, Germany.
Christoph KüperDepartment of Physiology, Ludwig-Maximilians-Universität München, Munich, Germany.
Franz-Xaver BeckDepartment of Physiology, Ludwig-Maximilians-Universität München, Munich, Germany.
Wolfgang NeuhoferV. Medical Clinic, University Hospital Mannheim, Mannheim, Germany.
Dominik N MullerExperimental and Clinical Research Center (ECRC), an institutional cooperation between the Charité Medical Faculty and the Max-Delbrück Center for Molecular Medicine, Berlin, Germany; Max-Delbrück Center for Molecular Medicine, Berlin Germany.
Gerold SchulerDepartment of Dermatology, Universitätsklinikum Erlangen and Friedrich-Alexander Universität (FAU) Erlangen-Nürnberg, Germany.
Michael UderDepartment of Radiology, Universitätsklinikum Erlangen and Friedrich-Alexander Universität (FAU) Erlangen-Nürnberg, Germany.
Christian BogdanMicrobiology Institute - Clinical Microbiology, Immunology and Hygiene, Universitätsklinikum Erlangen and Friedrich-Alexander Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.
Friedrich C LuftExperimental and Clinical Research Center (ECRC), an institutional cooperation between the Charité Medical Faculty and the Max-Delbrück Center for Molecular Medicine, Berlin, Germany; Divison of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Jens TitzeInterdisciplinary Center for Clinical Research and Department of Nephrology and Hypertension, Universitätsklinikum Erlangen and Friedrich-Alexander Universität (FAU) Erlangen-Nürnberg, Germany; Divison of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Universitätsklinikum Erlangen · DEMax Delbrück Center · DELudwig-Maximilians-Universität München · DEVanderbilt University · USCharité - Universitätsmedizin Berlin · DEMax Planck Institute for Molecular Genetics · DEUniversity Hospital Heidelberg · DEUniversity of Regensburg · DE

Funding

Lymphatic Regulation of Skin Electrolyte Metabolism and Blood PressureR01HL118579 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI TITZE, JENS MARC · 2013 to 2017
$1.9M
NHLBI NIH HHS R01 HL118579NHLBI NIH HHS R01 HL118579-01
6 · The paper itself

Abstract

Immune cells regulate a hypertonic microenvironment in the skin; however, the biological advantage of increased skin Na(+) concentrations is unknown. We found that Na(+) accumulated at the site of bacterial skin infections in humans and in mice. We used the protozoan parasite Leishmania major as a model of skin-prone macrophage infection to test the hypothesis that skin-Na(+) storage facilitates antimicrobial host defense. Activation of macrophages in the presence of high NaCl concentrations modified epigenetic markers and enhanced p38 mitogen-activated protein kinase (p38/MAPK)-dependent nuclear factor of activated T cells 5 (NFAT5) activation. This high-salt response resulted in elevated type-2 nitric oxide synthase (Nos2)-dependent NO production and improved Leishmania major control. Finally, we found that increasing Na(+) content in the skin by a high-salt diet boosted activation of macrophages in a Nfat5-dependent manner and promoted cutaneous antimicrobial defense. We suggest that the hypertonic microenvironment could serve as a barrier to infection.

Indexed as

AnimalsAnti-Infective AgentsEnzyme ActivationHumansLeishmania majorLeishmaniasis, CutaneousMacrophagesMiceNFATC Transcription FactorsNitric OxideNitric Oxide Synthase Type IIp38 Mitogen-Activated Protein KinasesSkinSodiumAnti-Infective AgentsNFATC Transcription FactorsNitric OxideNitric Oxide Synthase Type IIp38 Mitogen-Activated Protein KinasesSodium

Identifiers

PMID25738463
PMCPMC4350016
OpenAlexW2055323879

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.